Chris Cashman of Marinus Pharmaceuticals Inc.
joined us for World Orphan Drug Conference USA 2015 to present about '
Leading Innovation in Treatment of Epilepsy and Neuropsychiatric Disorders'
Download the presentation to learn about:
-
Ganaxalone: First-In-Class Therapeutic for Epilepsy and Neuropsychiatric Disorders
-
Diversified Clinical Stage Opportunities
-
Behaviors in Fragile X Syndrome
-
Intravenous Formulation
...and
much
more!
Get your copy here!
To find out more about
Marinus Pharmaceuticals and Gaxalone
, attend
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.